Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of pembrolizumab in cancer (Japan)
jRCT2080222935Phase 2Completed
- Start
- Aug 2015
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 2 trial of pembrolizumab in cancer. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222935.